News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
737,094 Results
Type
Article (42151)
Company Profile (189)
Press Release (694744)
Multimedia
Podcasts (98)
Webinars (21)
Section
Business (234640)
Career Advice (2045)
Deals (35676)
Drug Delivery (137)
Drug Development (82315)
Employer Resources (173)
FDA (16753)
Job Trends (15016)
News (348240)
Policy (32946)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2614)
Accelerated approval (56)
ADA (44)
Adcomms (29)
Allergies (195)
Alliances (49666)
ALS (230)
Alzheimer's disease (1870)
Antibody-drug conjugate (ADC) (532)
Approvals (17244)
Artificial intelligence (741)
ASCO (327)
Autoimmune disease (352)
Automation (63)
Bankruptcy (364)
Best Places to Work (11646)
BIO (69)
BIOSECURE Act (21)
Biosimilars (240)
Biotechnology (124)
Bladder cancer (207)
Brain cancer (76)
Breast cancer (810)
Cancer (6384)
Cardiovascular disease (525)
Career advice (1739)
Career pathing (45)
CAR-T (360)
CDC (58)
Celiac Disease (3)
Cell therapy (974)
Cervical cancer (56)
Clinical research (72240)
Collaboration (2235)
Commercialization (1)
Company closure (5)
Compensation (1533)
Complete response letters (88)
COVID-19 (2769)
CRISPR (120)
C-suite (1266)
Cystic fibrosis (159)
Data (8750)
Decentralized trials (3)
Denatured (30)
Depression (181)
Dermatology (102)
Diabetes (681)
Diagnostics (7062)
Digital health (65)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (368)
Drug pricing (204)
Drug shortages (32)
Duchenne muscular dystrophy (308)
Earnings (92329)
Editorial (70)
Employer branding (21)
Employer resources (155)
Events (120879)
Executive appointments (1138)
FDA (20840)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (36)
Funding (1874)
Gene editing (254)
Generative AI (63)
Gene therapy (755)
GLP-1 (1138)
Government (4771)
Grass and pollen (6)
Guidances (421)
Healthcare (19199)
Hematology (192)
HIV (91)
Huntington's disease (64)
IgA nephropathy (115)
Immunology and inflammation (310)
Immuno-oncology (106)
Indications (222)
Infectious disease (3143)
Inflammatory bowel disease (227)
Inflation Reduction Act (14)
Influenza (144)
Intellectual property (321)
Interviews (325)
IPO (16704)
IRA (50)
Job creations (3651)
Job search strategy (1438)
JPM (58)
Kidney cancer (21)
Labor market (112)
Layoffs (581)
Leadership (42)
Legal (7982)
Liver cancer (104)
Longevity (35)
Lung cancer (844)
Lymphoma (484)
Machine learning (65)
Management (61)
Manufacturing (1177)
Marketing (5)
MASH (212)
Medical affairs (1)
Medical device (14019)
Medtech (14199)
Mergers & acquisitions (20303)
Metabolic disorders (1697)
mRNA (237)
Multiple sclerosis (203)
NASH (22)
Neurodegenerative disease (474)
Neuropsychiatric disorders (112)
Neuroscience (3545)
Neurotech (1)
NextGen: Class of 2026 (6538)
Non-profit (4547)
Now hiring (83)
Obesity (789)
Opinion (299)
Ovarian cancer (242)
Pain (271)
Pancreatic cancer (356)
Parkinson's disease (400)
Partnered (36)
Patents (650)
Patient recruitment (790)
Peanut (67)
People (60016)
Pharmaceutical (45)
Pharmacy benefit managers (33)
Phase 1 (22466)
Phase 2 (31819)
Phase 3 (23722)
Pipeline (10067)
Policy (333)
Postmarket research (2604)
Preclinical (9506)
Press Release (64)
Prostate cancer (340)
Psychedelics (61)
Radiopharmaceuticals (348)
Rare diseases (1213)
Real estate (5975)
Recruiting (71)
Regulatory (26083)
Reports (56)
Research institute (2432)
Resumes & cover letters (356)
Rett syndrome (46)
RNA editing (25)
RSV (92)
Schizophrenia (186)
Series A (318)
Series B (234)
Service/supplier (7)
Sickle cell disease (123)
Special edition (25)
Spinal muscular atrophy (173)
Sponsored (48)
Startups (3656)
State (2)
Stomach cancer (18)
Supply chain (135)
Tariffs (87)
The Weekly (66)
Vaccines (1158)
Venture capital (122)
Weight loss (509)
Women's health (138)
Worklife (21)
Date
Last 7 days (407)
Last 30 days (1877)
Last 365 days (30430)
2026 (16845)
2025 (30262)
2024 (35211)
2023 (40170)
2022 (51288)
2021 (55823)
2020 (54168)
2019 (46651)
2018 (35109)
2017 (32194)
2016 (31583)
2015 (37637)
2014 (31442)
2013 (26459)
2012 (28651)
2011 (29355)
2010 (27428)
Location
Africa (745)
Alabama (95)
Alaska (7)
Arizona (367)
Arkansas (14)
Asia (40351)
Australia (6618)
California (14111)
Canada (4009)
China (1533)
Colorado (601)
Connecticut (617)
Delaware (436)
Europe (87060)
Florida (2143)
Georgia (452)
Hawaii (3)
Idaho (63)
Illinois (1170)
India (102)
Indiana (636)
Iowa (24)
Japan (601)
Kansas (135)
Kentucky (52)
Louisiana (58)
Maine (78)
Maryland (1673)
Massachusetts (10113)
Michigan (377)
Minnesota (760)
Mississippi (6)
Missouri (152)
Montana (33)
Nebraska (30)
Nevada (151)
New Hampshire (84)
New Jersey (3697)
New Mexico (30)
New York (3719)
North Carolina (1776)
North Dakota (9)
Northern California (7137)
Ohio (420)
Oklahoma (23)
Oregon (41)
Pennsylvania (2804)
Puerto Rico (31)
Rhode Island (52)
South America (1115)
South Carolina (90)
South Dakota (2)
Southern California (5609)
Tennessee (232)
Texas (2266)
United States (49798)
Utah (421)
Vermont (2)
Virginia (343)
Washington D.C. (81)
Washington State (1125)
West Virginia (4)
Wisconsin (133)
Wyoming (2)
737,094 Results for "anges mg inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 10 mg/kg in Entrada Therapeutics’ ELEVATE-45-201 Study
June 2, 2026
·
6 min read
Press Releases
Novo Nordisk’s CagriSema 2.4 mg / 2.4 mg demonstrated significant reduction in HbA1c and weight across multiple studies in the REIMAGINE program presented at ADA 2026
June 8, 2026
·
12 min read
Press Releases
Vasomune Therapeutics, Inc., and AnGes, Inc., Announce US FDA Clearance of Investigational New Drug (IND) Application For Pegevongitide (AV-001) Treatment in Resuscitation of Severely Burned Patients
March 4, 2026
·
3 min read
Press Releases
Nxera Pharma’s QUVIVIQ® (daridorexant) 25mg and 50mg Receives Approval in Taiwan for the Treatment of Insomnia
April 14, 2026
·
7 min read
Press Releases
Vasomune Therapeutics Inc., and AnGes Inc., Expand the Scope of the Co-Development Agreement to Target Additional Indications
November 26, 2025
·
2 min read
Press Releases
Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis
April 3, 2026
·
2 min read
Press Releases
People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more likely to achieve greater than 5% weight loss than those who were switched to tirzepatide, in real-world data
June 8, 2026
·
7 min read
Press Releases
Dr. Reddy’s Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif®, in the United States
June 15, 2026
·
4 min read
Press Releases
Samsung Bioepis Launches OPUVIZ™ (Aflibercept) 40 mg/mL Vial Across Europe, to Treat Ophthalmic Conditions
May 29, 2026
·
7 min read
Press Releases
SERB Pharmaceuticals Announces ThyroSafe 130 mg Potassium Iodide Tablets are Now Commercially Available in the US
May 7, 2026
·
4 min read
1 of 73,710
Next
